Introduction
It has been over a decade since the publication of the first highthroughput gene expression profiling studies of the brain (Hakak et al., 2001; Lockhart and Barlow, 2001; Mimmack et al., 2002; Mirnics et al., 2000; Pasinetti, 2001) . During the last decade the opinion and attitude of the scientific community has changed toward these technologies multiple times. The first phase, lasting about 3-4 years, was characterized by enthusiasm, excitement, and often unjustified optimism. Many viewed DNA microarray technology as a "magic bullet" that would fundamentally change our understanding of various brain disorders, and during this golden era of microarrays funding agencies were generous in supporting data-driven exploratory efforts. As a result, several important studies were generated, along with a large number of mediocre studies that resulted in long lists of gene dumpouts without meaningful interpretation of the findings. The backlash was predictable, and over a relatively short time period the dominant scientific opinion transformed itself to one of skepticism toward anything that was DNA microarray-generated. In the meanwhile, proteomics became "hot," followed by other novel "omics" technologies, and microarray expression studies fell in disgrace: microarray manuscripts started to be considered "descriptive studies", and as such they routinely started to receive editorial rejections by the top journals in the field of neuroscience. The attitude of many journals and editors was best summarized by the boilerplate rejection letter of the Journal of Neuroscience from 2005, stating that "We tend to be circumspect when we receive an expression array paper." (Journal-of-Neuroscience, 2005) -not caring about the quality of the presented science, but condemning the technology. Many microarray enthusiasts jumped on a bandwagon of new, hotter and better-funded "omic" technologies-while the real puritans of microarray technology went to work: they teamed up with expert teams of biostatisticians and bioinformaticians and started to generate standards of performing, reporting (Brazma et al., 2001) , analyzing (Irizarry et al., 2003; Subramanian et al., 2005; Tusher et al., 2001) and Neurobiology of Disease 45 (2012) 3-7 
